Overview

Study to Evaluate Resiniferatoxin in Patients With Knee Osteoarthritis Whose Total Knee Replacement Surgery is Delayed

Status:
Withdrawn

Trial end date:
2022-06-01

Target enrollment:

Participant gender:

Summary

Efficacy and safety study of resiniferatoxin versus placebo to manage pain in patients with knee osteoarthritis whose TKR surgery is delayed

Phase:

Phase 3

Details

Lead Sponsor:

Sorrento Therapeutics, Inc.